Peer Review History
| Original SubmissionMay 20, 2025 |
|---|
|
Dear Dr. Okello, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== Please address these comments including all the comments raised by reviewers 1 and 2. Ethical statement: “Ethical approval and consent to participate. The research protocol was submitted to Lira University's Faculty of Public Health and the Lira University Research and Ethic Committee for approval (LUREC-2024-235)”. Comment: the statement is unclear whether the study has been approved by the ethics committee or otherwise. Please be explicit about this. Introduction: Line 54: In Uganda, out of an estimated 1,492,742 people living with HIV, 1,255,975 are on ARVs (11). Comment: please provide percentage for ease of interpretation Methods: Study population: define adults Sampling: explain how simple random sampling was carried out Data collection: who collected the data, who conducted the interviews, which variables were collected through data abstraction, and which variables were collected through face-face interview? Data analysis: please present the section in logical order. The initial step will be data exportation to Stata and then analysis. Also explain whether the data was initially exported from EMR in MS Excel and then imported to Stata for further analysis? How about variables collected via face-face interview, were they electronically collected, manually in MS Excel e.t.c. please be explicit to ease reproducibility. Results: Line 169: majority aged 0-30; however, inclusion criterion says 18yrs and above. Table 2: label column 2. N? Discussion: Line 226-227 stated “In this study, we found that PLHIV receiving care in community models had higher rates of return to treatment as compared to those in the facility models.” However, results section Lines 187-188 stated that “Clients in the community care model had a lower return rate (83.9%) compared to those in the facility model (57.4%)”. Acknowledgement: Please acknowledge study participants. ============================== Please submit your revised manuscript by Oct 27 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. We look forward to receiving your revised manuscript. Kind regards, Jahun Ibrahim, MD, MSC, PhD Academic Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements.-->--> -->-->Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at -->-->https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and -->-->https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf-->--> -->-->2. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.-->--> -->-->3. Please amend either the title on the online submission form (via Edit Submission) or the title in the manuscript so that they are identical.-->--> -->-->4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.-->--> -->-->5. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. ?> Reviewers' comments: Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: No Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: Dear Editor, Thank you for the opportunity to review the manuscript "Factors Associated with Return to Treatment Following Interruption Among HIV-Positive Clients on ART in Public Health Facilities in Katakwi District, North Eastern Uganda". The study is timely and relevant, addressing the critical issue of treatment interruption and return to HIV care, particularly in rural Uganda—a context often underrepresented in research. Its mixed-methods approach, combining structured quantitative data with contextual insights, enhances understanding of the behavioral and structural factors influencing return to treatment. By grounding the analysis in local realities such as community beliefs, proximity to health facilities, and family support, the findings offer practical value for program design. Furthermore, the use of routine data from the OpenMRS system, triangulated with paper-based records, strengthens the validity and reliability of the results. However, there is room for improvement. Below are suggestions to help the authors to improve on the current draft and specific recommendations. General comments Language and grammar The manuscript would benefit from language polishing: • Typo: “client workers” instead of “clients” – Line 165 • Some long sentences, e.g.: “Clients coming from communities with strong beliefs against missing ART or treatment were about three times more likely...” could be re-worded, e.g. “Clients from communities with strong beliefs discouraging treatment interruption were nearly three times more likely to return to care than those from communities without such beliefs—consistent with findings from the United States and Tanzania.” It is not clear how the “strong believe” was measured or how these communities are organized into distinct groups with/without strong beliefs. Formatting • Please ensure that the intext citations are properly formatted, e.g., 42 and 30 in line 244 should appear as (42, 30) and not (42)(30). Also check similarly wrongly placed citations, e.g (35)(18) in line 235. • Some sentences start without a preceding full stop, e.g. the sentence that starts with the words “Facility and home-” Title The title is lengthy and will benefit from a revision. For example, a shorter form could be “Determinants of Return to HIV Treatment After Interruption in Katakwi District, Uganda” Abstract For better flow, the sentence that starts with the words “Despite these efforts...” needs some modifications to flow better. It is unclear which efforts are referred to. Introduction • The introduction is comprehensive but slightly repetitive in describing global/regional return-to-treatment statistics. • Consider clearly stating the research gap earlier in the introduction. Methods • Study design: Though the study follows STROBE, it claims to be mixed-method but only presents structured quantitative data. o Recommendation: Remove “mixed-method” or clarify any qualitative component. • Sampling and Exclusion Criteria: The rationale for excluding psychiatric patients and those admitted is not well explained. • Measurement of outcome (Return to Treatment): Defined as >28 days, which aligns with MOH guidance —but consider justifying the cutoff with references. • Variable Definitions: Several predictors are mentioned with yes/no responses—consider grouping by domain in a table. • It may have been helpful to include more facilities with varying levels, since patients may not return to referral facilities since they may prefer to seek care in facilities closest to them. This can be admitted as a limitation. • It is not clear why the two hospitals were selected as well and also, they seem to be at the same level. • The sentence “Return to treatment was assessed using frequency counts, percentages, and a 95% confidence interval” can be dropped or re-worded since this is not have been the tool used to assess the outcome variable. Consider describing the measures used for comparison of the proportions in the bivariate analysis. Results • Bivariate Table (Table 2): The formatting is inconsistent. For instance, the column “Yes (n=)” is incorrectly formatted. No need to repeat “...of respondent” for the variable Gender. The table title is also long and there is not point stating that the table is about “Bivariate analysis...” • Please be consistent with the number of decimal places for the p-values. Since the columns figures in brackets are percentages, the symbol can be included in the column headings and that it doesn’t have to be repeated. • Highlighting of the significant values should be consistent. For example, “Mode of care”. Consider ordering categories for ordinal variables. For example, “Distance to clinic” should start with <5kms. • Multivariate Table (Table 3): Should be better structured. Include sample size and N per group. Some p-values are misaligned. Discussion • Though it has a strong alignment with literature, some considerations on overstating the findings, e.g. in statements like “clients closer to facilities are less likely to return” require cautious interpretation. There may be possible confounding (e.g., stigma, facility congestion) should be hypothesized explicitly. It is surprising that clients who lived <5 kms to the clinic had the highest proportion of IIT, hence it may be challenging to explain why the significance without secondary analysis to rule out or consider stigma as a reason. Stigma alone may also not be the attributable factor since the type of facility and the services may differ depending on the type of facility. Clustering analysis may have been helpful. • The first sentence in the discussion needs rephrasing since use of the word “only” while referring to 63.9% is countered by the second sentence where the authors indicate that the rate of return is higher than other studies. The rate seems to be within the literature quoted in the second sentence. • In a vast rural setting, it is possible to contextualize access since some areas may be better connected than others. Hence the sentence “However, the geographical contribution to return to treatment cannot be fully contextualized within this study, as the study sites are in rural settings” may need further thought/reworking. • It would be helpful to add more explanation on why unemployed clients or those with certain beliefs are more or less likely to return. • In the limitations section, please remove the word “only” in line 259. In the limitation sentence “...we cannot establish a factor preceded or resulted from return to treatment,” needs substantiation since it is possible to do a competing risk analysis. Additionally, some outcomes such as viral suppression could have been considered since there is a temporal relationship with IIT. Conclusion • Thought practical and actionable, it could be more focused. Several recommendations are listed; grouping into themes (e.g., economic support, service delivery flexibility) would enhance clarity. • The sentence “We noted a high return to care rate that still falls short of the UNAIDS 95% target for return to care” needs to be revised since the commonly known 95-95-95 UNAIDS targets do not reference return to care. Line 261-62 References Some references are inconsistent, e.g. “11. Country P, Plan O. the People’s. 2020; 12. MOH. The 2019 HIV Epidemiological Surveillance Report for Uganda. file///C/Users/MARTIN%20ODOCHI/Downloads/2019-HIV-Epidemiological- Surveillance report-For print.pdf T 2019 HIV Accessed, 19/07/2021. 2019;(March 2020).” Reviewer #2: A good write up and wonderful insight. however, to include analysis on age and sex if available regression analysis need to also include inclusion and exclusion criteria. Can also include other form of graphic apart from tables use only. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Determinants of Return to HIV Treatment After Interruption on ART Among HIV Positive Clients in Katakwi District, Uganda. PONE-D-25-25853R1 Dear Dr. Okello, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Ibrahim Jahun, MD, MSC, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #2: Yes ********** Reviewer #2: The author has responded to all comments and the paper is well written and analysed. He is recommended ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #2: Yes: Ismail Lawal ********** |
| Formally Accepted |
|
PONE-D-25-25853R1 PLOS One Dear Dr. Okello, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Ibrahim Jahun Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .